Pacific Capital Partners LTD Royalty Pharma PLC Transaction History
Pacific Capital Partners LTD
- $158 Billion
- Q1 2025
A detailed history of Pacific Capital Partners LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Pacific Capital Partners LTD holds 175,000 shares of RPRX stock, worth $5.78 Million. This represents 3.45% of its overall portfolio holdings.
Number of Shares
175,000Holding current value
$5.78 Million% of portfolio
3.45%Shares
6 transactions
Others Institutions Holding RPRX
# of Institutions
455Shares Held
298MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.3 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$760 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$560 Million0.79% of portfolio
-
Baillie Gifford & CO13.4MShares$442 Million0.38% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...